Radiofrequency Balloon Catheter Market
Radiofrequency Balloon Catheter: Market Insights
Atrial fibrillation has become one of the major concern placing critical burden in healthcare systems. Atrial fibrillation is characterized by fast and irregular heartbeat that often results in uncoordinated contraction of the top chambers of the heart. According to Center for Disease Control and Prevention, an estimate of 2.7 to 6.1 million people suffer from atrial fibrillation in United States. Radiofrequency balloon catheter is used to examine the atrial fibrillation. Radiofrequency balloon catheter is designed to optimize efficacy and safety in the treatment of pulmonary vein isolation and also reduces the time. In radiofrequency balloon catheter technique, catheters from the femoral vein move to the left atrium with the help of radiofrequency energy. Radiofrequency energy is used in heating the tissue around the pulmonary veins and create a circular scar. With the increase in prevalence of the atrial fibrillation and pulmonary vein isolation, the radiofrequency balloon catheter market is shown to have increasing potential in near future.
Radiofrequency Balloon Catheter: Market Dynamics
Radiofrequency balloon catheter is expected to manifest considerable growth in the market due to increasing prevalence of atrial fibrillation and pulmonary vein isolation. In addition to this, the radiofrequency balloon catheter is proven to be safe and effective which as result will spur the growth of the market. However certain factors may hinder the growth of the market. Radiofrequency balloon catheter require skill trainer to perform the devices since it require more functions to operate the devices. Lack of well trainer may hamper the growth of the radiofrequency balloon catheter market. Also, the rate of reproducibility is less as compared to cryoballoon. Moreover, the cost of radiofrequency balloon catheter is high as compared to other catheter and this may hamper the growth of the radiofrequency balloon catheter market.
Radiofrequency Balloon Catheter Market: Segmentation
The global radiofrequency balloon catheter market is segmented by indication and end user.
Segmentation by Indication
Chronic haemorrhagic radiation proctitis
Malignant biliary strictures
Segmentation by End User
Hospitals
Clinics
Diagnostics Laboratories
Others
Radiofrequency Balloon Catheter Market: Overview
Radiofrequency balloon catheter market is witness to have significant growth in the market. Various manufacturers are currently developing radiofrequency balloon catheter which are currently in pipeline. For example, Biosense Webster, Inc. has developed one multi-electrode radiofrequency balloon catheter for the treatment of symptomatic paroxysmal atrial fibrillation. With the advancement of technology, the radiofrequency balloon catheter will spur the growth of the market. In addition to this, launch of new radiofrequency balloon catheter that are currently in pipeline will also foster the growth of the radiofrequency balloon catheter market.
Radiofrequency Balloon Catheter Market: Region-wise Outlook
On the basis of geography, the global radiofrequency balloon catheter market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is expected to manifest substantial share in radiofrequency balloon catheter market owing to increasing adoption of new technologies, increase in launch of radiofrequency balloon catheter and high healthcare infrastructure is likely to drive the growth of the radiofrequency balloon catheter market. Europe is expected to propel the growth of radiofrequency balloon catheter market due to adoption of new technology and increasing prevalence of atrial fibrillation will significantly foster the growth of the radiofrequency balloon catheter market. Asia Pacific has significant potential in accelerating the growth of the radiofrequency balloon catheter market due to increasing awareness among people for early diagnosis and treatment is likely to boost the growth of radiofrequency balloon catheter market. Japan also seems to have substantial growth in the radiofrequency balloon catheter market due to rising advancement in research and development, growing incidences of atrial fibrillation is anticipate to generate revenue for radiofrequency balloon catheter market. Middle East and Africa has witness less growth in radiofrequency balloon catheter market due to poor healthcare facilities and economy in the region may hamper the growth of radiofrequency balloon catheter market.
Radiofrequency Balloon Catheter Market: Key Players
Some of the key players present across the value chain of the global radiofrequency balloon catheter market are Medtronic, Biosense Webster, Inc.
The report covers exhaustive analysis on:
Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain
The regional analysis includes:
North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Report Highlights:
Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.
- 1. Executive Summary | Radiofrequency Balloon Catheter Market
- 1.1. Global Market Outlook
- 1.2. Demand-side Trends
- 1.3. Supply-side Trends
- 1.4. Technology Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Market Background
- 3.1. Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Restraints
- 3.1.3. Opportunity
- 3.1.4. Trends
- 3.2. Scenario Forecast
- 3.2.1. Demand in Optimistic Scenario
- 3.2.2. Demand in Likely Scenario
- 3.2.3. Demand in Conservative Scenario
- 3.3. Opportunity Map Analysis
- 3.4. Investment Feasibility Matrix
- 3.5. PESTLE and Porter’s Analysis
- 3.6. Regulatory Landscape
- 3.6.1. By Key Regions
- 3.6.2. By Key Countries
- 3.7. Regional Parent Market Outlook
- 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
- 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
- 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
- 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication
- 5.1. Introduction / Key Findings
- 5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021
- 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032
- 5.3.1. Chronic Haemorrhagic Radiation Proctitis
- 5.3.2. Malignant Biliary Strictures
- 5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021
- 5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021
- 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032
- 6.3.1. Hospitals
- 6.3.2. Clinics
- 6.3.3. Diagnostics Laboratories
- 6.3.4. Others
- 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
- 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
- 7.1. Introduction
- 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
- 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
- 7.3.1. North America
- 7.3.2. Latin America
- 7.3.3. Europe
- 7.3.4. Asia Pacific
- 7.3.5. Middle East and Africa
- 7.4. Market Attractiveness Analysis By Region
- 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 8.2.1. By Country
- 8.2.1.1. United Kingdom
- 8.2.1.2. Canada
- 8.2.2. By Indication
- 8.2.3. By End User
- 8.3. Market Attractiveness Analysis
- 8.3.1. By Country
- 8.3.2. By Indication
- 8.3.3. By End User
- 8.4. Key Takeaways
- 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 9.2.1. By Country
- 9.2.1.1. Brazil
- 9.2.1.2. Mexico
- 9.2.1.3. Rest of Latin America
- 9.2.2. By Indication
- 9.2.3. By End User
- 9.3. Market Attractiveness Analysis
- 9.3.1. By Country
- 9.3.2. By Indication
- 9.3.3. By End User
- 9.4. Key Takeaways
- 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 10.2.1. By Country
- 10.2.1.1. Germany
- 10.2.1.2. United Kingdom
- 10.2.1.3. France
- 10.2.1.4. Spain
- 10.2.1.5. Italy
- 10.2.1.6. Rest of Europe
- 10.2.2. By Indication
- 10.2.3. By End User
- 10.3. Market Attractiveness Analysis
- 10.3.1. By Country
- 10.3.2. By Indication
- 10.3.3. By End User
- 10.4. Key Takeaways
- 11. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 11.2.1. By Country
- 11.2.1.1. China
- 11.2.1.2. Japan
- 11.2.1.3. South Korea
- 11.2.1.4. Malaysia
- 11.2.1.5. Singapore
- 11.2.1.6. Australia
- 11.2.1.7. Rest of Asia Pacific
- 11.2.2. By Indication
- 11.2.3. By End User
- 11.3. Market Attractiveness Analysis
- 11.3.1. By Country
- 11.3.2. By Indication
- 11.3.3. By End User
- 11.4. Key Takeaways
- 12. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
- 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
- 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
- 12.2.1. By Country
- 12.2.1.1. GCC Countries
- 12.2.1.2. South Africa
- 12.2.1.3. Israel
- 12.2.1.4. Rest of Middle East and Africa
- 12.2.2. By Indication
- 12.2.3. By End User
- 12.3. Market Attractiveness Analysis
- 12.3.1. By Country
- 12.3.2. By Indication
- 12.3.3. By End User
- 12.4. Key Takeaways
- 13. Key Countries Market Analysis
- 13.1. United Kingdom
- 13.1.1. Pricing Analysis
- 13.1.2. Market Share Analysis, 2021
- 13.1.2.1. By Indication
- 13.1.2.2. By End User
- 13.2. Canada
- 13.2.1. Pricing Analysis
- 13.2.2. Market Share Analysis, 2021
- 13.2.2.1. By Indication
- 13.2.2.2. By End User
- 13.3. Brazil
- 13.3.1. Pricing Analysis
- 13.3.2. Market Share Analysis, 2021
- 13.3.2.1. By Indication
- 13.3.2.2. By End User
- 13.4. Mexico
- 13.4.1. Pricing Analysis
- 13.4.2. Market Share Analysis, 2021
- 13.4.2.1. By Indication
- 13.4.2.2. By End User
- 13.5. Rest of Latin America
- 13.5.1. Pricing Analysis
- 13.5.2. Market Share Analysis, 2021
- 13.5.2.1. By Indication
- 13.5.2.2. By End User
- 13.6. Germany
- 13.6.1. Pricing Analysis
- 13.6.2. Market Share Analysis, 2021
- 13.6.2.1. By Indication
- 13.6.2.2. By End User
- 13.7. United Kingdom
- 13.7.1. Pricing Analysis
- 13.7.2. Market Share Analysis, 2021
- 13.7.2.1. By Indication
- 13.7.2.2. By End User
- 13.8. France
- 13.8.1. Pricing Analysis
- 13.8.2. Market Share Analysis, 2021
- 13.8.2.1. By Indication
- 13.8.2.2. By End User
- 13.9. Spain
- 13.9.1. Pricing Analysis
- 13.9.2. Market Share Analysis, 2021
- 13.9.2.1. By Indication
- 13.9.2.2. By End User
- 13.10. Italy
- 13.10.1. Pricing Analysis
- 13.10.2. Market Share Analysis, 2021
- 13.10.2.1. By Indication
- 13.10.2.2. By End User
- 13.11. Rest of Europe
- 13.11.1. Pricing Analysis
- 13.11.2. Market Share Analysis, 2021
- 13.11.2.1. By Indication
- 13.11.2.2. By End User
- 13.12. China
- 13.12.1. Pricing Analysis
- 13.12.2. Market Share Analysis, 2021
- 13.12.2.1. By Indication
- 13.12.2.2. By End User
- 13.13. Japan
- 13.13.1. Pricing Analysis
- 13.13.2. Market Share Analysis, 2021
- 13.13.2.1. By Indication
- 13.13.2.2. By End User
- 13.14. South Korea
- 13.14.1. Pricing Analysis
- 13.14.2. Market Share Analysis, 2021
- 13.14.2.1. By Indication
- 13.14.2.2. By End User
- 13.15. Malaysia
- 13.15.1. Pricing Analysis
- 13.15.2. Market Share Analysis, 2021
- 13.15.2.1. By Indication
- 13.15.2.2. By End User
- 13.16. Singapore
- 13.16.1. Pricing Analysis
- 13.16.2. Market Share Analysis, 2021
- 13.16.2.1. By Indication
- 13.16.2.2. By End User
- 13.17. Australia
- 13.17.1. Pricing Analysis
- 13.17.2. Market Share Analysis, 2021
- 13.17.2.1. By Indication
- 13.17.2.2. By End User
- 13.18. Rest of Asia Pacific
- 13.18.1. Pricing Analysis
- 13.18.2. Market Share Analysis, 2021
- 13.18.2.1. By Indication
- 13.18.2.2. By End User
- 13.19. GCC Countries
- 13.19.1. Pricing Analysis
- 13.19.2. Market Share Analysis, 2021
- 13.19.2.1. By Indication
- 13.19.2.2. By End User
- 13.20. South Africa
- 13.20.1. Pricing Analysis
- 13.20.2. Market Share Analysis, 2021
- 13.20.2.1. By Indication
- 13.20.2.2. By End User
- 13.21. Israel
- 13.21.1. Pricing Analysis
- 13.21.2. Market Share Analysis, 2021
- 13.21.2.1. By Indication
- 13.21.2.2. By End User
- 13.22. Rest of the Middle East and Africa
- 13.22.1. Pricing Analysis
- 13.22.2. Market Share Analysis, 2021
- 13.22.2.1. By Indication
- 13.22.2.2. By End User
- 14. Market Structure Analysis
- 14.1. Competition Dashboard
- 14.2. Competition Benchmarking
- 14.3. Market Share Analysis of Top Players
- 14.3.1. By Regional
- 14.3.2. By Indication
- 14.3.3. By End User
- 15. Competition Analysis
- 15.1. Competition Deep Dive
- 15.1.1. Medtronic
- 15.1.1.1. Overview
- 15.1.1.2. Product Portfolio
- 15.1.1.3. Profitability by Market Segments
- 15.1.1.4. Sales Footprint
- 15.1.1.5. Strategy Overview
- 15.1.1.5.1. Marketing Strategy
- 15.1.2. Biosense Webster
- 15.1.2.1. Overview
- 15.1.2.2. Product Portfolio
- 15.1.2.3. Profitability by Market Segments
- 15.1.2.4. Sales Footprint
- 15.1.2.5. Strategy Overview
- 15.1.2.5.1. Marketing Strategy
- 15.1.3. Koninklijke Philips
- 15.1.3.1. Overview
- 15.1.3.2. Product Portfolio
- 15.1.3.3. Profitability by Market Segments
- 15.1.3.4. Sales Footprint
- 15.1.3.5. Strategy Overview
- 15.1.3.5.1. Marketing Strategy
- 15.1.4. Abbott Laboratories
- 15.1.4.1. Overview
- 15.1.4.2. Product Portfolio
- 15.1.4.3. Profitability by Market Segments
- 15.1.4.4. Sales Footprint
- 15.1.4.5. Strategy Overview
- 15.1.4.5.1. Marketing Strategy
- 15.1.5. Boston Scientific Corporation
- 15.1.5.1. Overview
- 15.1.5.2. Product Portfolio
- 15.1.5.3. Profitability by Market Segments
- 15.1.5.4. Sales Footprint
- 15.1.5.5. Strategy Overview
- 15.1.5.5.1. Marketing Strategy
- 15.1.6. B. Braun Melsungen
- 15.1.6.1. Overview
- 15.1.6.2. Product Portfolio
- 15.1.6.3. Profitability by Market Segments
- 15.1.6.4. Sales Footprint
- 15.1.6.5. Strategy Overview
- 15.1.6.5.1. Marketing Strategy
- 15.1.7. Terumo Corporation
- 15.1.7.1. Overview
- 15.1.7.2. Product Portfolio
- 15.1.7.3. Profitability by Market Segments
- 15.1.7.4. Sales Footprint
- 15.1.7.5. Strategy Overview
- 15.1.7.5.1. Marketing Strategy
- 15.1.8. Teleflex Incorporated
- 15.1.8.1. Overview
- 15.1.8.2. Product Portfolio
- 15.1.8.3. Profitability by Market Segments
- 15.1.8.4. Sales Footprint
- 15.1.8.5. Strategy Overview
- 15.1.8.5.1. Marketing Strategy
- 15.1.9. Nordson Corporation.
- 15.1.9.1. Overview
- 15.1.9.2. Product Portfolio
- 15.1.9.3. Profitability by Market Segments
- 15.1.9.4. Sales Footprint
- 15.1.9.5. Strategy Overview
- 15.1.9.5.1. Marketing Strategy
- 15.1.10. Becton, Dickinson, and Company
- 15.1.10.1. Overview
- 15.1.10.2. Product Portfolio
- 15.1.10.3. Profitability by Market Segments
- 15.1.10.4. Sales Footprint
- 15.1.10.5. Strategy Overview
- 15.1.10.5.1. Marketing Strategy
- 16. Assumptions & Acronyms Used
- 17. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook